What is the appropriate diagnostic and therapeutic approach for adrenal insufficiency in ICU patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adrenal Insufficiency in ICU Patients

In ICU patients with suspected adrenal insufficiency, do not delay treatment to perform diagnostic testing—immediately administer hydrocortisone 100 mg IV bolus followed by 200 mg/24h (either as 50 mg IV every 6 hours or continuous infusion) in patients with vasopressor-dependent septic shock, while diagnostic testing offers limited clinical utility in guiding treatment decisions. 11

Diagnostic Approach

When to Suspect Critical Illness-Related Corticosteroid Insufficiency (CIRCI)

Suspect CIRCI in any hypotensive ICU patient who responds poorly to fluid resuscitation and vasopressors, particularly in septic shock. Key clinical clues include:

  • Refractory hypotension despite adequate fluids and vasopressors
  • Hyponatremia and hyperkalemia without clear alternative cause
  • Unexplained hypoglycemia
  • Persistent hemodynamic instability 2

Diagnostic Testing: Limited Clinical Utility

The 2017 SCCM/ESICM guidelines make no recommendation for or against using either the ACTH stimulation test (delta cortisol <9 μg/dL at 60 minutes after 250 μg cosyntropin) or random cortisol (<10 μg/dL) to diagnose CIRCI. 11 This represents a significant shift from 2008 recommendations, reflecting that:

  • Clinicians have not adopted these diagnostic criteria in routine practice
  • The Surviving Sepsis Campaign explicitly recommends against using ACTH stimulation testing to select patients for hydrocortisone treatment in septic shock 1
  • The test does not predict who will benefit from corticosteroid therapy 3

Critical pitfall: Do not withhold corticosteroids while awaiting test results in vasopressor-dependent septic shock. If you must perform testing, use dexamethasone 4 mg initially (does not interfere with cortisol assays), then perform the ACTH stimulation test before switching to hydrocortisone 2.

Treatment Approach

Septic Shock with Vasopressor Dependence

Hydrocortisone 200 mg/day is recommended for patients with vasopressor-dependent septic shock, administered as:

  • 50 mg IV every 6 hours, OR
  • Continuous infusion at 200-240 mg/24h (approximately 10 mg/hour)
  • Duration: Minimum 7 days 13

Do not use high-dose "pulse" corticosteroids (methylprednisolone ≥30 mg/kg/day)—these provide no benefit and may cause harm. 2

Acute Respiratory Distress Syndrome (ARDS)

For severe early ARDS (PaO₂/FiO₂ <200 within 14 days of onset):

  • Methylprednisolone 1 mg/kg/day for ≥14 days 3

Adrenal Crisis Management

If frank adrenal crisis is suspected (severe hypotension, altered mental status, electrolyte abnormalities):

Immediate treatment:

  1. Hydrocortisone 100 mg IV bolus immediately
  2. 0.9% sodium chloride 10-20 mL/kg IV bolus, repeat as needed
  3. Monitor and correct hypoglycemia (target glucose >3.5 mmol/L)
  4. Start continuous hydrocortisone infusion 200 mg/24h or 50 mg IV every 6 hours 44

Fludrocortisone is not required acutely when high-dose hydrocortisone is given (hydrocortisone has mineralocorticoid activity at these doses). Add fludrocortisone 0.05-0.1 mg daily only when transitioning to maintenance therapy 44.

Weaning Strategy

Never stop corticosteroids abruptly in ICU patients. 3

Taper approach:

  • Continue full stress doses until hemodynamically stable off vasopressors
  • Gradually reduce over several days
  • Monitor for recurrence of hypotension, worsening oxygenation, or sepsis signs
  • Be prepared to reinstitute full doses if clinical deterioration occurs 3

Key Controversies and Nuances

The concept of "relative adrenal insufficiency" remains controversial 56. The 2017 guidelines deliberately use the term "critical illness-related corticosteroid insufficiency" to encompass both inadequate cortisol production and tissue corticosteroid resistance 1. The challenge is that no clinically useful test measures tissue glucocorticoid action, making diagnosis inherently problematic 5.

The evidence supports treatment based on clinical syndrome (vasopressor-dependent septic shock) rather than biochemical testing results. This pragmatic approach prioritizes mortality reduction over diagnostic precision 13.

What NOT to Do

  • Do not use dexamethasone for CIRCI treatment (lacks mineralocorticoid activity) 3
  • Do not use the ACTH test to decide who receives corticosteroids in septic shock 1
  • Do not delay treatment for diagnostic testing in unstable patients 44
  • Do not use high-dose pulse steroids 2

Related Questions

How should stress-dose glucocorticoid therapy be initiated and tapered in a critically ill patient with suspected adrenal insufficiency?
What physiologic changes occur during induction of anesthesia in a patient with adrenal insufficiency?
What are the clinical manifestations of adrenal insufficiency and which laboratory tests should be ordered to evaluate it?
Should a patient with an ACTH level of 1.5 ng/mL go to the emergency department?
What is the appropriate management approach for a ventilated stroke patient with cerebral edema who develops adrenal insufficiency presenting with hypotension and high-grade fever?
How is an induced sputum eosinophil count performed?
What is the appropriate management of acute renal insufficiency in an ICU patient?
In a 71‑year‑old woman with a two‑month history of daily bilateral ankle pain (right greater than left), swelling without erythema, no fever, no recent trauma, pain that worsens toward the end of the day and improves with leg elevation, and a normal right‑ankle radiograph, what is the most likely diagnosis and appropriate management?
What is the appropriate pseudoephedrine dosage and treatment duration for an adult patient with nasal congestion who has asthma and is using a fluticasone‑salmeterol (Advair) inhaler?
What is the interpretation of this complete blood count: RBC 5.96 ×10⁶/µL (elevated), hemoglobin 11.2 g/dL (low‑normal), hematocrit 39.7 % (normal), mean corpuscular volume 67 fL (low), mean corpuscular hemoglobin 18.8 pg (low), mean corpuscular hemoglobin concentration 28.2 g/dL (low), red cell distribution width 16.0 % (high)?
How does a subdural hygroma increase the risk of intracranial bleeding in a patient taking a direct oral anticoagulant (DOAC)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.